Research and analysis

COVID-19: PHE laboratory assessments of inactivation methods

PHE has undertaken assessments of inactivation methods against SARS-CoV-2 with further evaluations ongoing.

From:
Public Health England
Published
8 July 2020
Last updated
4 May 2021 — See all updates

Documents

HCM-CoV2-077-v1_DiaSorin_LIAISON_SARS-CoV-2 Ag_Inactivation_Buffer_TCF

Ref: GW-8122

PDF, 149 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM-CoV2-076-v1 Mologic_COVID_19_Rapid_Antigen_Test _(Swab)_Buffer_TCF

Ref: GW-8122

PDF, 118 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM-CoV2-075-v1_Hypochlorous_Acid_F_K_Holdings_TCF

Ref: GW-8122

PDF, 133 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM-CoV2-074-v1_ScheBo_SARS_CoV_2_Quick_Antigen_Extraction_Buffer_TCF

Ref: GW-8122

PDF, 118 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM-CoV2-073-v1_Zeesan_Saliva_RNA_Sample_Collection_Kit_buffer_TCF

Ref: GW-8122

PDF, 119 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM-CoV2-072-v1_LGC_Salicovgel- TCF

Ref: GW-8122

PDF, 119 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM-CoV2-071-v2_GeneMe_SAVD_Buffer_TCF

Ref: GW-8122

PDF, 131 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM-CoV2-070-v1_GeneMe_FRANKD_Buffer_TCF

Ref: GW-8122

PDF, 116 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM-CoV2-061-v2 Novacyt_PROmate_Sample_Preparation_Buffer _Triton_X_100_(standard)_TCF

PDF, 118 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM/CoV2/068/v1 MELT V4 Buffer

Ref: PHE publications gateway number GW-1859

PDF, 212 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM/CoV2/067/v1 MELT V3 Buffer

Ref: PHE publications gateway number GW-1859

PDF, 212 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM/CoV2/066/v2 Veritor Extraction Reagent

Ref: PHE publications gateway number GW-1859

PDF, 216 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM/CoV2/065/v1 Salicovgel-1

Ref: PHE publications gateway number GW-1859

PDF, 212 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM/CoV2/064/v1 MicroLYSIS-RNA Direct to PCR Lysis Solution

Ref: PHE publications gateway number GW-1859

PDF, 213 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM/CoV2/063/v1 ID NOW COVID-19 Elution Buffer

Ref: PHE publications gateway number GW-1859

PDF, 215 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM/CoV2/062/v1 taco Sample Storage Solution

Ref: PHE publications gateway number GW-1859

PDF, 215 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM-CoV2-061-v2 Novacyt_PROmate_Sample_Preparation_Buffer _Triton_X_100_(standard)_TCF

Ref: GW-8122

PDF, 115 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM-CoV2-060-v2_Novacyt_PROmate_Sample_Preparation_Buffer_(Triton X-100 reduced)_TCF

Ref: GW-8122

PDF, 115 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM/CoV2/059/v1 virusPHIX-P9

Ref: PHE publications gateway number GW-1859

PDF, 214 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM/CoV2/058/v1 MELT V1

Ref: PHE publications gateway number GW-1859

PDF, 213 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM/CoV2/057/v1 virusPHIX-CU

Ref: PHE publications gateway number GW-1859

PDF, 212 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM/CoV2/056/v1 ESPLINE SARS-CoV-2 Sample Extraction Solution

Ref: PHE publications gateway number GW-1859

PDF, 214 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM-CoV2-055-v1 VirusPHIX-LV

Ref: PHE publications gateway number GW-1725

PDF, 353 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM-CoV2-054-v1 Biomonde Lysis Buffer

Ref: PHE publications gateway number GW-1725

PDF, 361 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM-CoV2-053-v1 Deepblue COVID-19 Antigen Test Extraction Reagent

Ref: PHE publications gateway number GW-1725

PDF, 352 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM-CoV2-052-v1 Orient Gene Coronavirus Ag Rapid Test Buffer

Ref: PHE publications gateway number GW-1725

PDF, 353 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM-CoV2-051-v1 70% Acetone

Ref: PHE publications gateway number GW-1859

PDF, 242 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM-CoV2-050-v1 70% Isopropanol

Ref: PHE publications gateway number GW-1859

PDF, 228 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM-CoV2-049-v1 Abbott Panbio COVID-19 Rapid Test Device Buffer

PDF, 353 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM-CoV2-048-v1 Innova Extraction Solution

Ref: PHE publications gateway number GW-1725

PDF, 353 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM-CoV2-047-v1 Standard Q COVID-19 Ag Saliva Extraction Buffer

Ref: PHE publications gateway number GW-1725

PDF, 353 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM-CoV2-046-v2 VitaPCR Buffer

Ref: PHE publications gateway number GW-1725

PDF, 371 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 inactivation testing: interim report HCM/CoV2/045/v2 LumiraDx

Ref: PHE publications gateway number: GW-1694

PDF, 186 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM-CoV2-044-v1 1% Virkon

Ref: PHE publications gateway number GW-1725

PDF, 356 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM-CoV2-043-v3 Ethanol TCF

Ref: PHE publications gateway number GW-1859

PDF, 243 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM-CoV2-042-v1 Zeesan Biotech Buffer 401108

Ref: PHE publications gateway number GW-1725

PDF, 356 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM-CoV2-041-v1 Zeesan Biotech Buffer 401120

Ref: PHE publications gateway number GW-1725

PDF, 357 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM-CoV2-040-v2 D-Biotech

Ref: PHE publications gateway number GW-1725

PDF, 376 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM-CoV2-039-v2 Omnigene

Ref: PHE publications gateway number GW-1725

PDF, 356 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM/CoV2/038/v4 Standard Q COVID-19 Ag Extraction Buffer

Ref: PHE publications GW-1859

PDF, 219 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM-CoV2-037-v2 Arcis Buffer

Ref: PHE publications gateway number GW-1725

PDF, 381 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM-CoV2-036-v3 GeneFix Buffer

Ref: PHE publications gateway number GW-1725

PDF, 355 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM-CoV2-035-v3 BuccalFiX Buffer

Ref: PHE publications gateway number GW-1725

PDF, 357 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

HCM-CoV2-034-v2 virusPHIX

Ref: PHE publications gateway number GW-1725

PDF, 378 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 inactivation testing: interim report HCM/CoV2/033/v1 EO Lysis Buffer

Ref: PHE publications gateway number: GW-1464

PDF, 95.1 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 inactivation testing: interim report HCM/CoV2/032/v1 EO VPSS

Ref: PHE publications gateway number: GW-1464

PDF, 205 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 inactivation testing: interim report HCM-CoV2-031-v1 PHMB

Ref: PHE publications gateway number: GW-1464

PDF, 201 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 inactivation testing: interim report HCM-CoV2-030-v1 Copan eNAT

Ref: PHE publications gateway number: GW-1464

PDF, 208 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 inactivation testing: interim report HCM-CoV2-029-v2 MELT Medium B

Ref: PHE publications gateway number: GW-1464

PDF, 189 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 inactivation testing: interim report HCM-CoV2-028-v1 MELT Medium A

Ref: PHE publications gateway number: GW-1464

PDF, 190 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 inactivation testing: interim report HCM-CoV2-027-v1 Vstrip Extraction Buffer

Ref: PHE publications gateway number: GW-1464

PDF, 190 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 inactivation testing: interim report HCM-CoV2-026-v1 Samba SCoV Buffer

Ref: PHE publications gateway number: GW-1464

PDF, 188 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 inactivation testing: interim report HCM-CoV2-025-v1 NP40

Ref: PHE publications gateway number: GW-1464

PDF, 190 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 inactivation testing: interim report HCM-CoV2-024-v1 SDS

Ref: PHE publications gateway number: GW-1464

PDF, 188 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 inactivation testing: interim report HCM/CoV2/023/v1 Triton™ X-100

Ref: PHE publications gateway number GW-1373

PDF, 324 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 inactivation testing: interim report HCM/CoV2/022/v1 Virus Transport and Preservation Medium (Inactivated)

Ref: PHE publications gateway number GW-1373

PDF, 326 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 inactivation testing: interim report HCM/CoV2/021/v1 NeuMoDx™ Viral Lysis Buffer

Ref: PHE publications gateway number GW-1373

PDF, 323 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 inactivation testing: interim report HCM-CoV2-019-v3 4M GITC

Ref: PHE publications gateway number: GW-1464

PDF, 211 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 inactivation testing: interim report HCM/CoV2/019/v2 GITC 4M Transport Medium

Ref: PHE publications gateway number GW-1373

PDF, 332 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 inactivation testing: interim report HCM/CoV2/018/v2 AVL + ethanol TCF

Ref: PHE publications gateway number GW-1373

PDF, 324 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 inactivation testing: interim report HCM/CoV2/017/v2 MagNA Pure 96 External Lysis Buffer

Ref: PHE publications gateway number GW-1373

PDF, 323 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 inactivation testing: interim report HCM/CoV2/016/v2 PrimeStore Molecular Transport Medium (MTM)

Ref: PHE publications gateway number GW-1373

PDF, 325 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 inactivation testing: interim report HCM/CoV2/015/v2 cobas® Omni LYS reagent

Ref: PHE publications gateway number GW-1373

PDF, 325 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 inactivation testing: interim report HCM/CoV2/014/v3 GHCl 40% (w/v) Transport Medium

Ref: PHE publications gateway number GW-137

PDF, 331 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 inactivation testing: interim report HCM/CoV2/013/v3 GITC 2M Transport Medium

Ref: PHE publications gateway number GW-1373

PDF, 332 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 inactivation testing: interim report HCM/CoV2/012/v2 Buffer AVL

Ref: PHE publications gateway number GW-1373

PDF, 323 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 inactivation testing: interim report HCM-CoV2-009-v3 Heat Treatment

Ref: PHE publications gateway number: GW-1464

PDF, 210 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 inactivation testing: interim report HCM/CoV/008/v3 Buffer RLT + 1% β-mercaptoethanol

Ref: PHE publications gateway number GW-1373

PDF, 329 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 inactivation testing: interim report HCM/CoV2/007/v2 Aptima® Specimen Transport Medium

Ref: PHE publications gateway number GW-1373

PDF, 348 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 inactivation testing: interim report HCM/CoV2/006/v3 Triton™ X-100

Ref: PHE publications gateway number GW-1373

PDF, 335 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 inactivation testing: interim report HCM/CoV2/005/v3 Tween® 20 (synonym: polysorbate 20)

Ref: PHE publications gateway number GW-1373

PDF, 323 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 inactivation testing: interim report HCM/CoV2/004/v3 Cobas® PCR Media

Ref: PHE publications gateway number GW-1373

PDF, 327 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 inactivation testing: interim report HCM/CoV2/003/v4 Panther Fusion™ Specimen Lysis Tubes

Ref: PHE publications gateway number GW-1373

PDF, 326 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 inactivation testing: interim report HCM/CoV2/002/v4 Sigma MM™

Ref: PHE publications gateway number GW-1373

PDF, 325 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SARS-CoV-2 inactivation testing: interim report HCM/CoV/001/v4 Nuclisens® Lysis Buffer

Ref: PHE publications gateway number GW-1373

PDF, 327 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Public Health England (PHE) has undertaken assessments of inactivation methods against SARS-CoV-2.

Included here are a series of individual interim inactivation reports with further evaluations ongoing.

These reports will be useful for COVID-19 testing laboratories developing workflows that include an inactivation step and will aid the generation of suitable and sufficient risk assessments.

These assessments are now published by UK Health Security Agency.

Updates to this page

Published 8 July 2020
Last updated 4 May 2021 + show all updates

  1. Added 11 SARS-CoV-2 inactivation testing interim reports.

  2. Added 12 new reports and updated 043, 050 and 051.

  3. Added updated version of 'HCM-CoV2-043-v3 Ethanol TCF'.

  4. Added reports 34 to 55.

  5. Added 2 SARS-CoV-2 inactivation testing interim reports.

  6. Added 12 SARS-CoV-2 inactivation testing interim reports.

  7. First published.

Sign up for emails or print this page

Related content